{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T09:50:12Z","timestamp":1777369812195,"version":"3.51.4"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,6,9]],"date-time":"2017-06-09T00:00:00Z","timestamp":1496966400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Tissue Res"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1007\/s00441-017-2636-6","type":"journal-article","created":{"date-parts":[[2017,6,9]],"date-time":"2017-06-09T01:04:29Z","timestamp":1496970269000},"page":"93-104","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Advances in renal genetic diagnosis"],"prefix":"10.1007","volume":"369","author":[{"given":"Carsten","family":"Bergmann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,6,9]]},"reference":[{"key":"2636_CR1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.md.0000200165.90373.9a","volume":"85","author":"M Adeva","year":"2006","unstructured":"Adeva M, El-Youssef M, Rossetti S (2006) Clinical and molecular characterization defines a broadened spectrum of autosomal recessive polycystic kidney disease (ARPKD). Medicine (Baltimore) 85:1\u201321","journal-title":"Medicine (Baltimore)"},{"key":"2636_CR2","doi-asserted-by":"crossref","first-page":"481","DOI":"10.5858\/arpa.2014-0250-CP","volume":"139","author":"N Aziz","year":"2015","unstructured":"Aziz N, Zhao Q, Bry L, Driscoll DK, Funke B, Gibson JS, Grody WW, Hegde MR, Hoeltge GA, Leonard DG, Merker JD, Nagarajan R, Palicki LA, Robetorye RS, Schrijver I, Weck KE, Voelkerding KV (2015) College of American Pathologists\u2019 laboratory standards for next-generation sequencing clinical tests. Arch Pathol Lab Med 139:481\u2013493","journal-title":"Arch Pathol Lab Med"},{"key":"2636_CR3","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s00467-013-2706-2","volume":"30","author":"C Bergmann","year":"2015","unstructured":"Bergmann C (2015) ARPKD and early manifestations of ADPKD: the original polycystic kidney disease and phenocopies. Pediatr Nephrol 30:15\u201330","journal-title":"Pediatr Nephrol"},{"key":"2636_CR4","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1007\/s00431-011-1553-z","volume":"171","author":"C Bergmann","year":"2012","unstructured":"Bergmann C (2012) Educational paper: ciliopathies. Eur J Pediatr 171:1285\u20131300","journal-title":"Eur J Pediatr"},{"key":"2636_CR5","doi-asserted-by":"crossref","unstructured":"Bergmann C, Bothmer J von, Ortiz Bruchle N, Venghaus A, Frank V, Fehrenbach H, Hampel T, Pape L, Buske A, Jonsson J, Sarioglu N, Santos A, Ferreira JC, Becker JU, Cremer R, Hoefele J, Benz MR, Weber LT, Buettner R, Zerres K (2011) Mutations in multiple PKD genes may explain early and severe polycystic kidney disease. J Am Soc Nephrol 22:2047\u20132056","DOI":"10.1681\/ASN.2010101080"},{"key":"2636_CR6","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1681\/ASN.2012090884","volume":"24","author":"E Bresin","year":"2013","unstructured":"Bresin E, Rurali E, Caprioli J, Sanchez-Corral P, Fremeaux-Bacchi V, Rodriguez de Cordoba S, Pinto S, Goodship TH, Alberti M, Ribes D, Valoti E, Remuzzi G, Noris M, European Working Party on Complement Genetics in Renal Diseases (2013) Combined complement gene mutations in atypical hemolytic uremic syndrome influence clinical phenotype. J Am Soc Nephrol 24:475\u2013486","journal-title":"J Am Soc Nephrol"},{"key":"2636_CR7","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.cca.2015.12.011","volume":"453","author":"V Chanavat","year":"2016","unstructured":"Chanavat V, Janin A, Millat G (2016) A fast and cost-effective molecular diagnostic tool for genetic diseases involved in sudden cardiac death. Clin Chim Acta 453:80\u201385","journal-title":"Clin Chim Acta"},{"key":"2636_CR8","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1681\/ASN.2012070650","volume":"24","author":"E Cornec-Le Gall","year":"2013","unstructured":"Cornec-Le Gall E, Audr\u00e9zet M-P, Chen J-M, Hourmant M, Morin M-P, Perrichot R, Charasse C, Whebe B, Renaudineau E, Jousset P, Guillodo M-P, Grall-Jezequel A, Saliou P, F\u00e9rec C, Le Meur Y (2013) Type of PKD1 mutation influences renal outcome in ADPKD. J Am Soc Nephrol 24:1006\u20131013","journal-title":"J Am Soc Nephrol"},{"key":"2636_CR9","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1586\/14737159.2015.976555","volume":"15","author":"TJ Koning de","year":"2015","unstructured":"de Koning TJ, Jongbloed JD, Sikkema-Raddatz B, Sinke RJ (2015) Targeted next-generation sequencing panels for monogenetic disorders in clinical diagnostics: the opportunities and challenges. Expert Rev Mol Diagn 15:61\u201370","journal-title":"Expert Rev Mol Diagn"},{"key":"2636_CR10","doi-asserted-by":"crossref","first-page":"2946","DOI":"10.1093\/ndt\/gft253","volume":"28","author":"C Deltas","year":"2013","unstructured":"Deltas C, Pierides A, Voskarides K (2013) Molecular genetics of familial hematuric diseases. Nephrol Dial Transplant 28:2946\u20132960","journal-title":"Nephrol Dial Transplant"},{"key":"2636_CR11","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/ki.2015.28","volume":"88","author":"KU Eckardt","year":"2015","unstructured":"Eckardt KU, Alper SL, Antignac C, Bleyer AJ, Chauveau D, Dahan K, Deltas C, Hosking A, Kmoch S, Rampoldi L, Wiesener M, Wolf MT, Devuyst O, Kidney Disease: Improving Global Outcomes (2015) Autosomal dominant tubulointerstitial kidney disease: diagnosis, classification, and management\u2014a KDIGO consensus report. Kidney Int 88:676\u2013683","journal-title":"Kidney Int"},{"key":"2636_CR12","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/nrneph.2014.216","volume":"11","author":"AB Fogo","year":"2014","unstructured":"Fogo AB (2014) Causes and pathogenesis of focal segmental glomerulosclerosis. Nat Rev Nephrol 11:76\u201387","journal-title":"Nat Rev Nephrol"},{"key":"2636_CR13","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1200\/JCO.2014.59.3665","volume":"33","author":"CJ Gallego","year":"2015","unstructured":"Gallego CJ, Shirts BH, Bennette CS, Guzauskas G, Amendola LM, Horike-Pyne M, Hisama FM, Pritchard CC, Grady WM, Burke W, Jarvik GP, Veenstra DL (2015) Next-generation sequencing panels for the diagnosis of colorectal cancer and polyposis syndromes: a cost-effectiveness analysis. J Clin Oncol 33:2084\u20132091","journal-title":"J Clin Oncol"},{"key":"2636_CR14","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nrc3844","volume":"15","author":"L Gossage","year":"2014","unstructured":"Gossage L, Eisen T, Maher ER (2014) VHL, the story of a tumour suppressor gene. Nat Rev Cancer 15:55\u201364","journal-title":"Nat Rev Cancer"},{"key":"2636_CR15","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/nrneph.2013.169","volume":"9","author":"F Grahammer","year":"2013","unstructured":"Grahammer F, Schell C, Huber TB (2013) The podocyte slit diaphragm\u2014from a thin grey line to a complex signalling hub. Nat Rev Nephrol 9:587\u2013598","journal-title":"Nat Rev Nephrol"},{"key":"2636_CR16","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1053\/j.ackd.2013.10.001","volume":"21","author":"NB Haas","year":"2014","unstructured":"Haas NB, Nathanson KL (2014) Hereditary kidney cancer syndromes. Adv Chronic Kidney Dis 21:81\u201390","journal-title":"Adv Chronic Kidney Dis"},{"key":"2636_CR17","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1172\/JCI72272","volume":"124","author":"PC Harris","year":"2014","unstructured":"Harris PC, Torres VE (2014) Genetic mechanisms and signaling pathways in autosomal dominant polycystic kidney disease. J Clin Invest 124:2315\u20132324","journal-title":"J Clin Invest"},{"key":"2636_CR18","doi-asserted-by":"crossref","unstructured":"Hehir-Kwa JY, Claustres M, Hastings RJ, Ravenswaaij-Arts C van, Christenhusz G, Genuardi M, Melegh B, Cambon-Thomsen A, Patsalis P, Vermeesch J, Cornel MC, Searle B, Palotie A, Capoluongo E, Peterlin B, Estivill X, Robinson PN (2015) Towards a European consensus for reporting incidental findings during clinical NGS testing. Eur J Hum Genet 23:1601\u20131606","DOI":"10.1038\/ejhg.2015.111"},{"key":"2636_CR19","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1681\/ASN.2006121344","volume":"18","author":"F Hildebrandt","year":"2007","unstructured":"Hildebrandt F, Zhou W (2007) Nephronophthisis-associated ciliopathies. J Am Soc Nephrol 18:1855\u20131871","journal-title":"J Am Soc Nephrol"},{"key":"2636_CR20","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1007\/s00467-014-2856-x","volume":"29","author":"JA Kari","year":"2014","unstructured":"Kari JA, Montini G, Bockenhauer D, Brennan E, Rees L, Trompeter RS, Tullus K, Van\u2019t Hoff W, Waters A, Ashton E, Lench N, Sebire NJ, Marks SD (2014) Clinico-pathological correlations of congenital and infantile nephrotic syndrome over twenty years. Pediatr Nephrol 29:2173\u20132180","journal-title":"Pediatr Nephrol"},{"key":"2636_CR21","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.pediatrneurol.2013.08.002","volume":"49","author":"DA Krueger","year":"2013","unstructured":"Krueger DA, Northrup H, International Tuberous Sclerosis Complex Consensus Group (2013) Tuberous sclerosis complex surveillance and management: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference. Pediatr Neurol 49:255\u2013265","journal-title":"Pediatr Neurol"},{"key":"2636_CR22","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.trsl.2014.11.003","volume":"165","author":"WB LaRiviere","year":"2014","unstructured":"LaRiviere WB, Irazabal MV, Torres VE (2014) Novel therapeutic approaches to autosomal dominant polycystic kidney disease. Transl Res 165:488-498","journal-title":"Transl Res"},{"key":"2636_CR23","doi-asserted-by":"crossref","unstructured":"Loirat C, Fakhouri F, Ariceta G, Besbas N, Bitzan M, Bjerre A, Coppo R, Emma F, Johnson S, Karpman D, Landau D, Langman CB, Lapeyraque AL, Licht C, Nester C, Pecoraro C, Riedl M, Kar NC van de, Van de Walle J, Vivarelli M, Fremeaux-Bacchi V, HUS International (2016) An international consensus approach to the management of atypical hemolytic uremic syndrome in children. Pediatr Nephrol 31:15\u201339","DOI":"10.1007\/s00467-015-3076-8"},{"key":"2636_CR24","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/ejhg.2015.226","volume":"24","author":"G Matthijs","year":"2016","unstructured":"Matthijs G, Souche E, Alders M, Corveleyn A, Eck S, Feenstra I, Race V, Sistermans E, Sturm M, Weiss M, Yntema H, Bakker E, Scheffer H, Bauer P, EuroGentest; European Society of Human Genetics (2016) Guidelines for diagnostic next-generation sequencing. Eur J Hum Genet 24:2\u20135","journal-title":"Eur J Hum Genet"},{"key":"2636_CR25","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/nrg2626","volume":"11","author":"ML Metzker","year":"2010","unstructured":"Metzker ML (2010) Sequencing technologies\u2014the next generation. Nat Rev Genet 11:31\u201346","journal-title":"Nat Rev Genet"},{"key":"2636_CR26","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/ki.2014.229","volume":"86","author":"JH Miner","year":"2014","unstructured":"Miner JH, Baigent C, Flinter F, Gross O, Judge P, Kashtan CE, Lagas S, Savige J, Blatt D, Ding J, Gale DP, Midgley JP, Povey S, Prunotto M, Renault D, Skelding J, Turner AN, Gear S (2014) The 2014 International Workshop on Alport syndrome. Kidney Int 86:679\u2013684","journal-title":"Kidney Int"},{"key":"2636_CR27","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/nrneph.2013.280","volume":"10","author":"M Noris","year":"2014","unstructured":"Noris M, Remuzzi G (2014) Cardiovascular complications in atypical haemolytic uraemic syndrome. Nat Rev Nephrol 10:174\u2013180","journal-title":"Nat Rev Nephrol"},{"key":"2636_CR28","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1053\/j.ackd.2014.06.001","volume":"21","author":"MR Pollak","year":"2014","unstructured":"Pollak MR (2014) Familial FSGS. Adv Chronic Kidney Dis 21:422\u2013425","journal-title":"Adv Chronic Kidney Dis"},{"key":"2636_CR29","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/nrg3463","volume":"14","author":"HL Rehm","year":"2013","unstructured":"Rehm HL (2013) Disease-targeted sequencing: a cornerstone in the clinic. Nat Rev Genet 14:295\u2013300","journal-title":"Nat Rev Genet"},{"key":"2636_CR30","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/gim.2013.92","volume":"15","author":"HL Rehm","year":"2013","unstructured":"Rehm HL, Bale SJ, Bayrak-Toydemir P, Berg JS, Brown KK, Deignan JL, Friez MJ, Funke BH, Hegde MR, Lyon E, Working Group of the American College of Medical Genetics and Genomics Laboratory Quality Assurance Commitee (2013) ACMG clinical laboratory standards for next-generation sequencing. Genet Med 15:733\u2013747","journal-title":"Genet Med"},{"key":"2636_CR31","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1055\/s-0034-1376153","volume":"40","author":"M Riedl","year":"2014","unstructured":"Riedl M, Fakhouri F, Le Quintrec M, Noone DG, Jungraithmayr TC, Fremeaux-Bacchi V, Licht C (2014) Spectrum of complement-mediated thrombotic microangiopathies: pathogenetic insights identifying novel treatment approaches. Semin Thromb Hemost 40:444\u2013464","journal-title":"Semin Thromb Hemost"},{"key":"2636_CR32","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s10545-014-9677-8","volume":"37","author":"SM Rombach","year":"2014","unstructured":"Rombach SM, Smid BE, Linthorst GE, Dijkgraaf MG, Hollak CE (2014) Natural course of Fabry disease and the effectiveness of enzyme replacement therapy: a systematic review and meta-analysis: effectiveness of ERT in different disease stages. J Inherit Metab Dis 37:341\u2013352","journal-title":"J Inherit Metab Dis"},{"key":"2636_CR33","doi-asserted-by":"crossref","first-page":"958","DOI":"10.5858\/arpa.2015-0507-RA","volume":"140","author":"S Roy","year":"2016","unstructured":"Roy S, LaFramboise WA, Nikiforov YE, Nikiforova MN, Routbort MJ, Pfeifer J, Nagarajan R, Carter AB, Pantanowitz L (2016) Next-generation sequencing informatics: challenges and strategies for implementation in a clinical environment. Arch Pathol Lab Med 140:958\u2013975","journal-title":"Arch Pathol Lab Med"},{"key":"2636_CR34","doi-asserted-by":"crossref","unstructured":"Schmid S, Gillessen S, Binet I, Brandle M, Engeler D, Greiner J, Hader C, Heinimann K, Kloos P, Krek W, Krull I, Stoeckli SJ, Sulz MC, Leyen K van, Weber J, Rothermundt C, Hundsberger T (2014) Management of von Hippel-Lindau disease: an interdisciplinary review. Oncol Res Treat 37:761\u2013771","DOI":"10.1159\/000369362"},{"key":"2636_CR35","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1186\/s12885-015-1254-5","volume":"15","author":"T Snowsill","year":"2015","unstructured":"Snowsill T, Huxley N, Hoyle M, Jones-Hughes T, Coelho H, Cooper C, Frayling I, Hyde C (2015) A model-based assessment of the cost-utility of strategies to identify lynch syndrome in early-onset colorectal cancer patients. BMC Cancer 15:313","journal-title":"BMC Cancer"},{"key":"2636_CR36","doi-asserted-by":"crossref","first-page":"531","DOI":"10.3389\/fimmu.2014.00531","volume":"5","author":"JL Stoddard","year":"2014","unstructured":"Stoddard JL, Niemela JE, Fleisher TA, Rosenzweig SD (2014) Targeted NGS: a cost-effective approach to molecular diagnosis of PIDs. Front Immunol 5:531","journal-title":"Front Immunol"},{"key":"2636_CR37","doi-asserted-by":"crossref","unstructured":"Weiss MM, Van der Zwaag B, Jongbloed JD, Vogel MJ, Bruggenwirth HT, Lekanne Deprez RH, Mook O, Ruivenkamp CA, Slegtenhorst MA van, Wijngaard A van den, Waisfisz Q, Nelen MR, Stoep N van der (2013) Best practice guidelines for the use of next-generation sequencing applications in genome diagnostics: a national collaborative study of Dutch genome diagnostic laboratories. Hum Mutat 34:1313\u20131321","DOI":"10.1002\/humu.22368"},{"key":"2636_CR38","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/nrneph.2012.214","volume":"8","author":"J Zuber","year":"2012","unstructured":"Zuber J, Fakhouri F, Roumenina LT, Loirat C, Fremeaux-Bacchi V, French Study Group for aHUS\/C3G (2012) Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies. Nat Rev Nephrol 8:643\u2013657","journal-title":"Nat Rev Nephrol"}],"container-title":["Cell and Tissue Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00441-017-2636-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00441-017-2636-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00441-017-2636-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,20]],"date-time":"2017-06-20T10:11:15Z","timestamp":1497953475000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00441-017-2636-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,9]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["2636"],"URL":"https:\/\/doi.org\/10.1007\/s00441-017-2636-6","relation":{},"ISSN":["0302-766X","1432-0878"],"issn-type":[{"value":"0302-766X","type":"print"},{"value":"1432-0878","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,9]]}}}